A phase 1 study of FluBHPVE6E7 immunotherapy in patients with HPV16-associated oropharyngeal squamous cell carcinoma
BS-03
Phase 1 other active
Quick answer
A phase 1 study of FluBHPVE6E7 immunotherapy in patients with HPV16-associated oropharyngeal squamous cell carcinoma for Treatment of human papilloma virus (HPV) associated infections and cancers is a Phase 1 program (other) at Blue Earth Diagnostics Ireland Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Blue Earth Diagnostics Ireland Ltd
- Indication
- Treatment of human papilloma virus (HPV) associated infections and cancers
- Phase
- Phase 1
- Modality
- other
- Status
- active